MetaCap

PMGC (ELAB) vs Jupiter Neurosciences (JUNS)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Jupiter Neurosciences is the larger company by market cap ($1.6 million vs $1.3 million), about 1.2 times the size. PMGC converts more of its revenue into profit, with a net margin of -1313.0% versus -39662.8%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ELAB-63.69%JUNS-56.51%
+22%-23%-68%
Oct 7, 20261 yearNov 20, 2026
ELAB-62.99%JUNS-56.67%
+8%-29%-66%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ELAB versus JUNS key metrics
MetricELABJUNS
Share price$1.14$1.24
Market cap$1.33M$1.63M
1-day change-10.24%-18.75%
Forward P/E—20.58
EPS (TTM)$-555.60$-22.53
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$590.08K$21.80K
Net income (latest FY)$-7.75M$-8.64M
Gross margin31.40%80.59%
Operating margin—-40873.19%
Net margin-1313.00%-39662.77%
52-week high$1,344.00$97.73
52-week low$1.14$1.20
Distance from 52-week high-99.92%-98.74%
Average volume279.01K69.86K
Shares outstanding1.17M1.32M
Employees325
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • PMGC is more profitable, keeping -1313.0 cents of every revenue dollar as net income versus -39662.8 cents for Jupiter Neurosciences.

About PMGC

ELAB stock →

PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of aesthetic medicines and therapeutic products. It operates through three segments: corporate, treasury and biosciences; IT packaging solutions; and precision engineering and machining.

Health Care · Biotechnology: Pharmaceutical Preparations · 32 employees

About Jupiter Neurosciences

JUNS stock →

Jupiter Neurosciences, Inc., a clinical stage research and development pharmaceutical company, engages in the development of therapeutics for central nervous system disorders and rare diseases in the United States and internationally. It operates in two segments, Pharmaceutical Operations and Premium Nutritional Supplements.

Health Care · Biotechnology: Pharmaceutical Preparations · 5 employees

ELAB vs JUNS FAQ

Which is bigger, PMGC or Jupiter Neurosciences?

Jupiter Neurosciences (JUNS) is larger, with a market capitalization of $1.63M compared with $1.33M for PMGC (ELAB).

Are PMGC and Jupiter Neurosciences in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons